Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-02

Clinical Trial Update: Antioxidant Supplementation in Pregnant Women [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated antioxidant supplementation in pregnant women to prevent or treat preeclampsia; results were posted in December 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antioxidant supplementation (unspecified) (unspecified antioxidant)

Snippet

Sponsor: Showa University | Conditions: Pregnant Women, Preeclampsia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2010-12-02